Evidence map›Paper›PMID 41032429›Full record

ReviewRevista de la Facultad de Ciencias Medicas (Cordoba, Argentina)2025

[ Most prevalent oral diseases in patients with visual impairment]

Julián Maya Sierra, María José Palencia Naranjo, Yussy Morales Moreno, Luis Fabian Benítez-Moreno, Eilien Tovío-Martínez

Abstract readReviewEnglish Abstract
In one paragraph

Review in Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Julián Maya SierraInstitución Universitaria Visión de las Américas.
María José Palencia NaranjoInstitución Universitaria Visión de las Américas.
Yussy Morales MorenoInstitución Universitaria Visión de las Américas.
Luis Fabian Benítez-MorenoInstitución Universitaria Visión de las Américas.
Eilien Tovío-MartínezInstitución Universitaria Visión de las Américas.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To determine the most prevalent oral diseases in the visually impaired population. Methods: The search on oral diseases in the visually impaired was carried out in databases, web resources and the reference list of selected articles, including those in English and/or Spanish, published between 2000 and 2023 and all types of methodological studies of original articles. The information was synthesized using frequencies for country, year of study and type of research. Results: 254 publications were found, of which 33 met the analysis criteria: 16 from India, three from Colombia, two from Iran, two from China, two from Kuwait and the remainder from different countries such as Yemen, Sudan, United Kingdom, Saudi Arabia, Thailand, Malaysia, Brazil and Mexico. Of the studies 72.73% (n = 24) evaluated prevalence of dental caries, another 33% (n = 11) dental trauma, 75.76% (n = 25) soft and hard bacterial plaque, 3.03% (n = 1) quality of life, 15.15% (n = 5) dental malocclusion, another 57.58% (n = 19) gingival and/or periodontal condition and 24.24% (n = 8) other lesions or clinical findings. The main pathology reported was periodontal disease and/or gingival involvement. Conclusion: The visually impaired are susceptible to early dental loss due to caries or periodontal disease, the proportions vary according to age group, however, women are generally the most affected.

Indexed as

Mouth DiseasesPersons with Visual DisabilitiesFemaleHumansMalePrevalenceblindnessdentistrymouth diseasesoral healthpathology oralvisually impaired persons

Identifiers

PMID41032429
PMCPMC12707205

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.